Anamed says optic gel could make $75 million by 2004
This article was originally published in Clinica
Executive Summary
Development-stage company Anamed is looking to realise revenues of around $75 million by 2004 through the development of its surgical technology for farsightedness. An company IPO is envisioned for 2003/4.